Glycosylated hemoglobin: the importance in management of type 2 diabetes

Glycosylated hemoglobin: the importance in management of type 2 diabetes

Автор: Yavari Abbas

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 4 т.7, 2011 года.

Бесплатный доступ

Type 2 diabetes is a major public health problem with high and increasing prevalence, morbidity and mortality. The association between diabetes and microvascular and macrovascular complications is well known besides, tight glycemic control is a necessity. HbA1Chas clinically been used since 1980s as a gold standard for monitoring glycemic control and predicting of diabetic complications. The present review article was prepared by computerized sources of literature searches 2000 - 2009. The history of Hemoglobin A1C, its assay techniques, optimal A1C targets, its reliability in control of diabetic complications, limitations of test results and its importance in control of diabetes patients and their complications are discussed.

Еще

Glycemic control, hba1c, type 2 diabetes

Короткий адрес: https://sciup.org/14323544

IDR: 14323544

Список литературы Glycosylated hemoglobin: the importance in management of type 2 diabetes

  • Bloomgarden ZT. (2008). American college of endocrinology pre-diabetes consensus conference: Part three. Diabetes Care. 31, 2404-2409.
  • Bode BW, Irvin BR, Pierce JA, Allen M, Clark AN. (2007). Advances in hemoglobin A1Cpoint of care technology. J Diabetes Sci Technol. 3, 319-321.
  • Brewer N, Wright CS, Travier N, Cunningham CW, Hornell J, Pearce N, et al. (2008). A New Zealand linkage study examining the associations between A1Cconcentration and mortality. Diabetes Care. 31, 1144-1149.
  • Brownlee M & Hirsch IB. (2006). Glycemic variability: A hemoglobin A1Cindependent risk factor for diabetic complications. JAMA. 295, 1707-1708.
  • Buse JB, Ginsberg HN, Bakris GL, Clark NG, Fonseca V. (2007). Primary prevention of cardiovascular diseases in people with diabetes mellitus. Circulation. 115, 114-126.
  • Cefalu WT. (2008). Glycemic targets and cardiovascular disease. N Engl J Med. 358, 2633-2635.
  • Dailey G. (2009). Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A1C measurements. Available at: http://www.mayoclinicproceedings.com/content/82/2/229.full.4/27/2009>.
  • Day C & Bailey CJ. (2007). control is important. J Diabetes Vasc Dis. 7, 197-198.
  • El-Kebbi JM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phpllips LS. (2003). Association of younger age with poor glycemic control and obesty in urban African American with type 2 diabetes. Arch Intern Med. 163, 69-75.
  • Gallagher EJ, LE Roith D, Bloomgarden Z. (2009). of hemoglobin A1Cin the management of diabetes. Diabetes. 1, 9-17.
  • Gerstein HC, Swedberg K, Carlsson J, McMurray JJV, Michelson EL, Olofsson B. et al, (2008). The hemoglobin A1Clevel as a progressive risk factor for cardiovascular death, hospitalization for heart failure or death in patients with chronic heart failure. Arch Inter Med. 168, 1699-1704.
  • Gilliland SS, Carter JS, Skipper BS, Action KI. (2002). HbA1C levels among American Indian/Alaska native adults. Diabetes Care. 25, 2178-2183.
  • Goldhaber JD, Goldhaber SN, Tristan ML, Nathan DM. (2003). Controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. Care. 26, 24-29.
  • Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. (2004). Tests of glycemia in diabetes. Diabetes Care. 27, 1761-1773.
  • Kahn R, Fonseca V. (2008). Translating the A1Cassay. Diabetes Care. 31, 1-4.
  • Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day A. (2004). Association of hemoglobin A1C cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 141, 413-420
  • Munter P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. (2005). Relationship between HbA1C and peripheral arterial disease. Diabetes Care. 28, 1981-1897
  • Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB; Owens DK. (2007). Glycemic control and type 2 diabetes mellitus: The optimal hemoglobin A1Ctargets. A guidance statement from the American College of Physicians. Ann Intern Med. 147, 417-422.
  • Saudek CD, Deer RL, Kaylani RR. (2006). Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1C. JAMA. 295, 1688-1697.
  • Selvin E, Marinopoulos S, Berkenbit G, Rami T, Brancati FL, Powe NR, et al. (2004). Intensive glucose control and cardiovascular outcomes. Ann Intern Med. 141, 421-431.
  • Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. (2006). HbA1Cand peripheral arterial disease in diabetes. Care. 29, 877-882
  • Shiraiwa T, Kaneto H, Miyatsuka T, Kato K, Yamamoto K, Kawashima A. (2005). hyperglycemia is a better of the progression of diabetic retinopathy than HbA1C in Japenes type 2 diabetic patients. Diabetes Care. 28, 2806-2809
  • Smaldone A. (2008). Glycemic control and hemoglobinopathy: When A1C may not be reliable. Diabetes Spectrum. 21, 46-49.
  • Tran HA, Sivla D, Petrovsky N. (2004). Case study: Potential pitfalls of using hemoglobin A1Cas the sole measure of glycemic control. Clin Diabetes. 22: 141-143
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp